tiprankstipranks
Trending News
More News >
China Innovation Investment Limited (HK:1217)
:1217
Hong Kong Market

China Innovation Investment Limited (1217) AI Stock Analysis

Compare
0 Followers

Top Page

HK

China Innovation Investment Limited

(1217)

Rating:51Neutral
Price Target:
HK$0.00
▼(-100.00%Downside)
The overall stock score reflects a mixed financial performance with strong revenue recovery but concerns over cash flow stability. Technical analysis suggests a lack of momentum, while valuation indicators point to potential overvaluation. The absence of earnings call and corporate events data limits further insights.

China Innovation Investment Limited (1217) vs. iShares MSCI Hong Kong ETF (EWH)

China Innovation Investment Limited Business Overview & Revenue Model

Company DescriptionChina Innovation Investment Limited invests in equity-related securities and debt instruments in listed and unlisted companies in Hong Kong and the People's Republic of China. It also engages in transactions comprising options and futures that are traded on recognized securities or futures exchanges and for the purpose of hedging. The company invests in information technology, telecommunications, manufacturing, service, property, infrastructure, life science, and environmental sectors. China Innovation Investment Limited, formerly nown as Sino Technology Investments Company Limited, was incorporated in 2002 and is based in Sheung Wan, Hong Kong.
How the Company Makes MoneyChina Innovation Investment Limited generates revenue through capital appreciation and dividends from its investments. The company invests in both listed and unlisted securities, aiming to benefit from the growth and profitability of its portfolio companies. Key revenue streams include returns on equity investments, interest income from debt securities, and dividends received from its holdings. Additionally, the company may engage in strategic partnerships or collaborative investment opportunities that enhance its investment portfolio's value, further contributing to its earnings.

China Innovation Investment Limited Financial Statement Overview

Summary
The company has shown a strong recovery in revenue and profit margins in 2024, with a net profit margin of 24.7%. However, historical volatility in revenue and net income, especially losses in 2021, raises concerns about stability. The balance sheet is robust with low leverage, but the lack of cash flow stability and negative cash flows present significant risks.
Income Statement
35
Negative
The company has shown significant revenue growth from 2023 to 2024, with a 549.5% increase. Gross profit margin is strong at 100%, indicating all revenue is contributing to profit. However, the historical volatility in revenue and net income, especially losses in 2021, raises concerns about stability. The net profit margin of 24.7% in 2024 is positive, but past inconsistencies impact the score.
Balance Sheet
75
Positive
The balance sheet is strong with a high equity ratio of 98.9% in 2024, indicating low financial leverage and a solid financial structure. The debt-to-equity ratio is minimal at 0.3%, reflecting low risk from debt obligations. The return on equity for 2024 is 0.9%, suggesting moderate efficiency in utilizing shareholder equity to generate profits.
Cash Flow
20
Very Negative
The cash flow statement shows a concerning lack of operating, investing, and financing cash flows in 2024, indicating potential issues with cash management or reporting. The absence of free cash flow growth and a historical pattern of negative cash flows highlight risks in liquidity and operational efficiency.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
20.26M3.12M20.15M-26.73M-3.64M
Gross Profit
19.15M2.15M19.22M-27.62M-4.55M
EBIT
5.82M2.27M5.80M-33.83M-9.75M
EBITDA
5.91M3.24M6.73M-32.94M-9.03M
Net Income Common Stockholders
5.00M2.19M5.76M-34.01M-9.88M
Balance SheetCash, Cash Equivalents and Short-Term Investments
299.84M177.96M137.63M156.54M225.14M
Total Assets
548.58M550.22M564.03M612.68M656.35M
Total Debt
1.38M2.23M475.00K1.39M2.26M
Net Debt
-212.21M-38.34M-6.18M-11.99M-14.55M
Total Liabilities
5.87M2.55M770.00K1.68M2.60M
Stockholders Equity
542.71M547.67M563.26M611.00M653.75M
Cash FlowFree Cash Flow
178.84M28.56M-15.37M-19.35M-1.77M
Operating Cash Flow
178.84M28.62M-14.95M-19.35M-1.77M
Investing Cash Flow
-4.97M6.18M9.14M16.79M6.78M
Financing Cash Flow
-854.00K-883.00K-915.00K-871.00K-894.00K

China Innovation Investment Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.01
Price Trends
50DMA
0.01
Negative
100DMA
0.01
Negative
200DMA
0.01
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
42.64
Neutral
STOCH
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1217, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.64 is Neutral, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1217.

China Innovation Investment Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$84.72B3.591.64%7.65%-13.56%-84.68%
64
Neutral
$12.93B9.707.85%78.03%12.07%-7.83%
63
Neutral
HK$503.10M7.992.12%-4.66%-77.08%
57
Neutral
HK$1.23B37.972.65%1.33%-60.81%-21.00%
51
Neutral
HK$128.02M25.000.92%545.43%100.00%
44
Neutral
HK$64.87M-2.19%5.28%86.91%
€1.16B17.224.34%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1217
China Innovation Investment Limited
0.01
0.00
0.00%
HK:0559
DeTai New Energy Group
0.12
-0.24
-66.67%
DE:MNA1
Yunfeng Financial Group Limited
0.17
0.09
112.50%
HK:2327
Meilleure Health International Industry Group Limited
0.30
0.12
66.67%
HK:0606
SCE Intelligent Commercial Management Holdings Limited
0.26
-0.04
-13.33%
HK:0087
Swire Pacific Limited Class B
10.96
1.20
12.30%

China Innovation Investment Limited Corporate Events

China Innovation Investment Limited Reports Net Asset Value
Jun 12, 2025

China Innovation Investment Limited announced its unaudited net asset value per share as of May 31, 2025, which stands at approximately HK$0.045. This announcement provides stakeholders with an insight into the company’s financial health and market positioning, potentially impacting investor confidence and future investment decisions.

China Innovation Investment Limited’s AGM Resolutions Unanimously Approved
May 23, 2025

China Innovation Investment Limited announced that all proposed resolutions at their 2024 Annual General Meeting were passed unanimously by shareholders. The resolutions included the re-election of independent non-executive directors, authorization of directors’ remuneration, re-appointment of auditors, and granting of a general mandate to the directors. This unanimous approval reflects strong shareholder support and positions the company for continued stability and strategic decision-making.

China Innovation Investment Limited Announces Partial Offer for Elife Holdings Shares
May 14, 2025

China Innovation Investment Limited has announced a pre-conditional voluntary cash partial offer by Mango Financial Limited to acquire 180,000,000 shares in Elife Holdings Limited, representing approximately 13.27% of its issued share capital. This move, subject to certain pre-conditions and conditions, aims to enhance the Offeror’s stake in Elife Holdings, potentially impacting the company’s market positioning and shareholder dynamics.

China Innovation Investment Limited Reports Net Asset Value Update
May 12, 2025

China Innovation Investment Limited announced that its unaudited net asset value per share was approximately HK$0.046 as of April 30, 2025. This financial update provides stakeholders with a snapshot of the company’s financial health, potentially impacting investor perception and market positioning.

China Innovation Investment Limited Announces 2025 AGM Agenda
Apr 17, 2025

China Innovation Investment Limited has announced its upcoming Annual General Meeting (AGM) to be held on May 23, 2025, in Hong Kong. The meeting will address several key issues, including the review of the company’s financial statements, re-election of directors, and re-appointment of auditors. Additionally, resolutions will be considered regarding the repurchase of company shares and the issuance of additional shares, which could impact the company’s market operations and shareholder value.

China Innovation Investment Limited Reports Net Asset Value
Apr 11, 2025

China Innovation Investment Limited announced that its unaudited net asset value per share as of March 31, 2025, was approximately HK$0.045. This update provides stakeholders with insight into the company’s financial position, which is crucial for assessing its market value and investment potential.

China Innovation Investment Limited Reports Increased Turnover and Profit for 2024
Mar 21, 2025

China Innovation Investment Limited reported a significant increase in turnover for the year ending December 31, 2024, reaching approximately HK$687.9 million compared to HK$387.6 million in 2023. The company achieved a net profit attributable to equity shareholders of approximately HK$5 million, up from HK$2.2 million in the previous year, driven by net realized gains on investment disposals. Despite the profit increase, the company’s net assets slightly decreased due to adverse economic conditions affecting the fair value of equity investments.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.